The Nasdaq 100 climbed as the FDA approval of a drug targeting Alzheimer’s disease bolstered the biotechnology sector. Asia-Pacific markets look set to open mixed. Bitcoin plunged below $34k mark.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
We and our partners store and/or access information on a device, such as unique IDs in cookies to process personal data. You may accept or manage your choices by clicking below, including your right to object where legitimate interest is used, or at any time in the privacy policy page. These choices will be signalled to our partners and will not affect browsing data.
We and our partners process data to provide:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience insights and product development.